Hamilton Lane Board Elects Michael Schmertzler as New Independent Director
Hamilton Lane elected Michael Schmertzler as a new independent director to its Board, effective July 22, 2026, bringing the total number of independent directors to five. Schmertzler brings decades of experience in investment and corporate finance, including former roles at Credit Suisse First Boston and Morgan Stanley, and currently serves as Chairman of PTC Therapeutics.
Key figures
- Aum usd
- $1 trillion
- Employee count
- 785
- Discretionary assets usd
- $141.8 billion
- Non discretionary assets usd
- $905.3 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.